nodes	percent_of_prediction	percent_of_DWPC	metapath
Terbutaline—BCHE—kidney cancer	0.885	1	CbGaD
Terbutaline—Allergic cutaneous angiitis—Sorafenib—kidney cancer	0.00532	0.0489	CcSEcCtD
Terbutaline—Leukocytoclastic vasculitis—Everolimus—kidney cancer	0.00397	0.0365	CcSEcCtD
Terbutaline—Leukocytoclastic vasculitis—Sorafenib—kidney cancer	0.00345	0.0317	CcSEcCtD
Terbutaline—Bambuterol—BCHE—kidney cancer	0.00241	0.418	CrCbGaD
Terbutaline—Chest discomfort—Everolimus—kidney cancer	0.0022	0.0202	CcSEcCtD
Terbutaline—Isoprenaline—MAPK1—kidney cancer	0.00204	0.354	CrCbGaD
Terbutaline—Chest discomfort—Paclitaxel—kidney cancer	0.00124	0.0114	CcSEcCtD
Terbutaline—Ventricular extrasystoles—Paclitaxel—kidney cancer	0.00121	0.0111	CcSEcCtD
Terbutaline—Flushing—Pazopanib—kidney cancer	0.00115	0.0106	CcSEcCtD
Terbutaline—Injection site pain—Capecitabine—kidney cancer	0.0011	0.0101	CcSEcCtD
Terbutaline—Muscle spasms—Pazopanib—kidney cancer	0.00104	0.00953	CcSEcCtD
Terbutaline—Chest discomfort—Capecitabine—kidney cancer	0.00101	0.00932	CcSEcCtD
Terbutaline—Ventricular extrasystoles—Capecitabine—kidney cancer	0.000993	0.00913	CcSEcCtD
Terbutaline—Chest pain—Temsirolimus—kidney cancer	0.000975	0.00896	CcSEcCtD
Terbutaline—Hallucination—Everolimus—kidney cancer	0.000974	0.00895	CcSEcCtD
Terbutaline—Anxiety—Temsirolimus—kidney cancer	0.000972	0.00893	CcSEcCtD
Terbutaline—Hypertonia—Paclitaxel—kidney cancer	0.000958	0.00881	CcSEcCtD
Terbutaline—Chest pain—Pazopanib—kidney cancer	0.000918	0.00844	CcSEcCtD
Terbutaline—Flushing—Everolimus—kidney cancer	0.000908	0.00835	CcSEcCtD
Terbutaline—Dry mouth—Pazopanib—kidney cancer	0.000898	0.00825	CcSEcCtD
Terbutaline—Clenbuterol—CYP1A1—kidney cancer	0.000877	0.152	CrCbGaD
Terbutaline—Hyperhidrosis—Pazopanib—kidney cancer	0.000851	0.00782	CcSEcCtD
Terbutaline—Insomnia—Temsirolimus—kidney cancer	0.000845	0.00777	CcSEcCtD
Terbutaline—Dyspnoea—Temsirolimus—kidney cancer	0.000833	0.00766	CcSEcCtD
Terbutaline—Somnolence—Temsirolimus—kidney cancer	0.000831	0.00764	CcSEcCtD
Terbutaline—Muscle spasms—Everolimus—kidney cancer	0.000819	0.00753	CcSEcCtD
Terbutaline—Tremor—Everolimus—kidney cancer	0.000798	0.00733	CcSEcCtD
Terbutaline—Insomnia—Pazopanib—kidney cancer	0.000796	0.00732	CcSEcCtD
Terbutaline—Paraesthesia—Pazopanib—kidney cancer	0.000791	0.00727	CcSEcCtD
Terbutaline—Flushing—Sorafenib—kidney cancer	0.000788	0.00724	CcSEcCtD
Terbutaline—Dyspnoea—Pazopanib—kidney cancer	0.000785	0.00721	CcSEcCtD
Terbutaline—Somnolence—Pazopanib—kidney cancer	0.000783	0.00719	CcSEcCtD
Terbutaline—Flushing—Sunitinib—kidney cancer	0.000759	0.00697	CcSEcCtD
Terbutaline—Palpitations—Everolimus—kidney cancer	0.000753	0.00692	CcSEcCtD
Terbutaline—Sweating—Vincristine—kidney cancer	0.000738	0.00678	CcSEcCtD
Terbutaline—Chest pain—Everolimus—kidney cancer	0.000725	0.00666	CcSEcCtD
Terbutaline—Anxiety—Everolimus—kidney cancer	0.000723	0.00664	CcSEcCtD
Terbutaline—Flushing—Dactinomycin—kidney cancer	0.000718	0.0066	CcSEcCtD
Terbutaline—Cramp muscle—Paclitaxel—kidney cancer	0.000715	0.00657	CcSEcCtD
Terbutaline—Muscle spasms—Sorafenib—kidney cancer	0.000711	0.00653	CcSEcCtD
Terbutaline—Dry mouth—Everolimus—kidney cancer	0.000709	0.00652	CcSEcCtD
Terbutaline—Injection site pain—Doxorubicin—kidney cancer	0.000708	0.00651	CcSEcCtD
Terbutaline—Sweating—Gemcitabine—kidney cancer	0.0007	0.00644	CcSEcCtD
Terbutaline—Chest pain—Erlotinib—kidney cancer	0.0007	0.00643	CcSEcCtD
Terbutaline—Anxiety—Erlotinib—kidney cancer	0.000697	0.00641	CcSEcCtD
Terbutaline—Hallucination—Vincristine—kidney cancer	0.000688	0.00632	CcSEcCtD
Terbutaline—Muscle spasms—Sunitinib—kidney cancer	0.000684	0.00629	CcSEcCtD
Terbutaline—Tachycardia—Everolimus—kidney cancer	0.000679	0.00624	CcSEcCtD
Terbutaline—Hyperhidrosis—Everolimus—kidney cancer	0.000672	0.00618	CcSEcCtD
Terbutaline—Asthenia—Temsirolimus—kidney cancer	0.000671	0.00616	CcSEcCtD
Terbutaline—Ventricular extrasystoles—Doxorubicin—kidney cancer	0.00064	0.00588	CcSEcCtD
Terbutaline—Asthenia—Pazopanib—kidney cancer	0.000632	0.00581	CcSEcCtD
Terbutaline—Insomnia—Everolimus—kidney cancer	0.000629	0.00578	CcSEcCtD
Terbutaline—Paraesthesia—Vinblastine—kidney cancer	0.000627	0.00576	CcSEcCtD
Terbutaline—Paraesthesia—Everolimus—kidney cancer	0.000624	0.00574	CcSEcCtD
Terbutaline—Dyspnoea—Everolimus—kidney cancer	0.00062	0.0057	CcSEcCtD
Terbutaline—Somnolence—Everolimus—kidney cancer	0.000618	0.00568	CcSEcCtD
Terbutaline—Dizziness—Temsirolimus—kidney cancer	0.000618	0.00568	CcSEcCtD
Terbutaline—Dry mouth—Sorafenib—kidney cancer	0.000616	0.00566	CcSEcCtD
Terbutaline—Insomnia—Erlotinib—kidney cancer	0.000607	0.00558	CcSEcCtD
Terbutaline—Chest pain—Sunitinib—kidney cancer	0.000606	0.00557	CcSEcCtD
Terbutaline—Dyspnoea—Erlotinib—kidney cancer	0.000598	0.0055	CcSEcCtD
Terbutaline—Vomiting—Temsirolimus—kidney cancer	0.000594	0.00546	CcSEcCtD
Terbutaline—Dry mouth—Sunitinib—kidney cancer	0.000592	0.00544	CcSEcCtD
Terbutaline—Rash—Temsirolimus—kidney cancer	0.000589	0.00542	CcSEcCtD
Terbutaline—Dermatitis—Temsirolimus—kidney cancer	0.000589	0.00541	CcSEcCtD
Terbutaline—Headache—Temsirolimus—kidney cancer	0.000585	0.00538	CcSEcCtD
Terbutaline—Dizziness—Pazopanib—kidney cancer	0.000582	0.00535	CcSEcCtD
Terbutaline—Vomiting—Pazopanib—kidney cancer	0.00056	0.00514	CcSEcCtD
Terbutaline—Rash—Pazopanib—kidney cancer	0.000555	0.0051	CcSEcCtD
Terbutaline—Nausea—Temsirolimus—kidney cancer	0.000555	0.0051	CcSEcCtD
Terbutaline—Dermatitis—Pazopanib—kidney cancer	0.000555	0.0051	CcSEcCtD
Terbutaline—Headache—Pazopanib—kidney cancer	0.000552	0.00507	CcSEcCtD
Terbutaline—Dyspnoea—Sorafenib—kidney cancer	0.000538	0.00494	CcSEcCtD
Terbutaline—Insomnia—Sunitinib—kidney cancer	0.000525	0.00483	CcSEcCtD
Terbutaline—Nausea—Pazopanib—kidney cancer	0.000523	0.00481	CcSEcCtD
Terbutaline—Paraesthesia—Sunitinib—kidney cancer	0.000521	0.00479	CcSEcCtD
Terbutaline—Dyspnoea—Sunitinib—kidney cancer	0.000518	0.00476	CcSEcCtD
Terbutaline—Flushing—Paclitaxel—kidney cancer	0.00051	0.00468	CcSEcCtD
Terbutaline—Hypertonia—Doxorubicin—kidney cancer	0.000507	0.00466	CcSEcCtD
Terbutaline—Asthenia—Vinblastine—kidney cancer	0.000501	0.0046	CcSEcCtD
Terbutaline—Asthenia—Everolimus—kidney cancer	0.000499	0.00458	CcSEcCtD
Terbutaline—Chest pain—Gemcitabine—kidney cancer	0.000486	0.00447	CcSEcCtD
Terbutaline—Asthenia—Erlotinib—kidney cancer	0.000481	0.00442	CcSEcCtD
Terbutaline—Hyperhidrosis—Vincristine—kidney cancer	0.000475	0.00436	CcSEcCtD
Terbutaline—Tension—Paclitaxel—kidney cancer	0.000469	0.00431	CcSEcCtD
Terbutaline—Nervousness—Paclitaxel—kidney cancer	0.000464	0.00427	CcSEcCtD
Terbutaline—Dizziness—Vinblastine—kidney cancer	0.000461	0.00424	CcSEcCtD
Terbutaline—Dizziness—Everolimus—kidney cancer	0.00046	0.00422	CcSEcCtD
Terbutaline—Muscle spasms—Paclitaxel—kidney cancer	0.00046	0.00422	CcSEcCtD
Terbutaline—Hyperhidrosis—Gemcitabine—kidney cancer	0.00045	0.00414	CcSEcCtD
Terbutaline—Tremor—Paclitaxel—kidney cancer	0.000448	0.00412	CcSEcCtD
Terbutaline—Insomnia—Vincristine—kidney cancer	0.000444	0.00408	CcSEcCtD
Terbutaline—Vomiting—Vinblastine—kidney cancer	0.000444	0.00408	CcSEcCtD
Terbutaline—Dizziness—Erlotinib—kidney cancer	0.000444	0.00408	CcSEcCtD
Terbutaline—Vomiting—Everolimus—kidney cancer	0.000442	0.00406	CcSEcCtD
Terbutaline—Paraesthesia—Vincristine—kidney cancer	0.000441	0.00405	CcSEcCtD
Terbutaline—Isoprenaline—CYP1A1—kidney cancer	0.000439	0.0761	CrCbGaD
Terbutaline—Rash—Everolimus—kidney cancer	0.000438	0.00403	CcSEcCtD
Terbutaline—Dermatitis—Everolimus—kidney cancer	0.000438	0.00402	CcSEcCtD
Terbutaline—Headache—Vinblastine—kidney cancer	0.000437	0.00402	CcSEcCtD
Terbutaline—Headache—Everolimus—kidney cancer	0.000436	0.004	CcSEcCtD
Terbutaline—Asthenia—Sorafenib—kidney cancer	0.000433	0.00398	CcSEcCtD
Terbutaline—Vomiting—Erlotinib—kidney cancer	0.000426	0.00392	CcSEcCtD
Terbutaline—Rash—Erlotinib—kidney cancer	0.000423	0.00389	CcSEcCtD
Terbutaline—Dermatitis—Erlotinib—kidney cancer	0.000423	0.00388	CcSEcCtD
Terbutaline—Palpitations—Paclitaxel—kidney cancer	0.000422	0.00388	CcSEcCtD
Terbutaline—Insomnia—Gemcitabine—kidney cancer	0.000421	0.00387	CcSEcCtD
Terbutaline—Headache—Erlotinib—kidney cancer	0.00042	0.00386	CcSEcCtD
Terbutaline—Paraesthesia—Gemcitabine—kidney cancer	0.000418	0.00384	CcSEcCtD
Terbutaline—Flushing—Capecitabine—kidney cancer	0.000418	0.00384	CcSEcCtD
Terbutaline—Asthenia—Sunitinib—kidney cancer	0.000417	0.00383	CcSEcCtD
Terbutaline—Dyspnoea—Gemcitabine—kidney cancer	0.000415	0.00382	CcSEcCtD
Terbutaline—Nausea—Vinblastine—kidney cancer	0.000415	0.00381	CcSEcCtD
Terbutaline—Somnolence—Gemcitabine—kidney cancer	0.000414	0.00381	CcSEcCtD
Terbutaline—Nausea—Everolimus—kidney cancer	0.000413	0.00379	CcSEcCtD
Terbutaline—Chest pain—Paclitaxel—kidney cancer	0.000407	0.00374	CcSEcCtD
Terbutaline—Anxiety—Paclitaxel—kidney cancer	0.000406	0.00373	CcSEcCtD
Terbutaline—Dizziness—Sorafenib—kidney cancer	0.000399	0.00367	CcSEcCtD
Terbutaline—Nausea—Erlotinib—kidney cancer	0.000398	0.00366	CcSEcCtD
Terbutaline—Dry mouth—Paclitaxel—kidney cancer	0.000398	0.00366	CcSEcCtD
Terbutaline—Asthenia—Dactinomycin—kidney cancer	0.000394	0.00362	CcSEcCtD
Terbutaline—Dizziness—Sunitinib—kidney cancer	0.000384	0.00353	CcSEcCtD
Terbutaline—Vomiting—Sorafenib—kidney cancer	0.000384	0.00353	CcSEcCtD
Terbutaline—Tachycardia—Paclitaxel—kidney cancer	0.000381	0.0035	CcSEcCtD
Terbutaline—Rash—Sorafenib—kidney cancer	0.00038	0.0035	CcSEcCtD
Terbutaline—Dermatitis—Sorafenib—kidney cancer	0.00038	0.00349	CcSEcCtD
Terbutaline—Headache—Sorafenib—kidney cancer	0.000378	0.00347	CcSEcCtD
Terbutaline—Muscle spasms—Capecitabine—kidney cancer	0.000377	0.00347	CcSEcCtD
Terbutaline—Hyperhidrosis—Paclitaxel—kidney cancer	0.000377	0.00347	CcSEcCtD
Terbutaline—Vomiting—Sunitinib—kidney cancer	0.000369	0.00339	CcSEcCtD
Terbutaline—Tremor—Capecitabine—kidney cancer	0.000368	0.00338	CcSEcCtD
Terbutaline—Rash—Sunitinib—kidney cancer	0.000366	0.00336	CcSEcCtD
Terbutaline—Dermatitis—Sunitinib—kidney cancer	0.000366	0.00336	CcSEcCtD
Terbutaline—Headache—Sunitinib—kidney cancer	0.000364	0.00334	CcSEcCtD
Terbutaline—Nausea—Sorafenib—kidney cancer	0.000358	0.00329	CcSEcCtD
Terbutaline—Insomnia—Paclitaxel—kidney cancer	0.000353	0.00324	CcSEcCtD
Terbutaline—Asthenia—Vincristine—kidney cancer	0.000352	0.00324	CcSEcCtD
Terbutaline—Paraesthesia—Paclitaxel—kidney cancer	0.00035	0.00322	CcSEcCtD
Terbutaline—Vomiting—Dactinomycin—kidney cancer	0.00035	0.00321	CcSEcCtD
Terbutaline—Dyspnoea—Paclitaxel—kidney cancer	0.000348	0.0032	CcSEcCtD
Terbutaline—Somnolence—Paclitaxel—kidney cancer	0.000347	0.00319	CcSEcCtD
Terbutaline—Palpitations—Capecitabine—kidney cancer	0.000347	0.00319	CcSEcCtD
Terbutaline—Rash—Dactinomycin—kidney cancer	0.000347	0.00319	CcSEcCtD
Terbutaline—Nausea—Sunitinib—kidney cancer	0.000345	0.00317	CcSEcCtD
Terbutaline—Asthenia—Gemcitabine—kidney cancer	0.000334	0.00307	CcSEcCtD
Terbutaline—Chest pain—Capecitabine—kidney cancer	0.000334	0.00307	CcSEcCtD
Terbutaline—Anxiety—Capecitabine—kidney cancer	0.000333	0.00306	CcSEcCtD
Terbutaline—Dry mouth—Capecitabine—kidney cancer	0.000327	0.003	CcSEcCtD
Terbutaline—Nausea—Dactinomycin—kidney cancer	0.000327	0.003	CcSEcCtD
Terbutaline—Dizziness—Vincristine—kidney cancer	0.000325	0.00298	CcSEcCtD
Terbutaline—Drowsiness—Doxorubicin—kidney cancer	0.000324	0.00297	CcSEcCtD
Terbutaline—Tachycardia—Capecitabine—kidney cancer	0.000312	0.00287	CcSEcCtD
Terbutaline—Vomiting—Vincristine—kidney cancer	0.000312	0.00287	CcSEcCtD
Terbutaline—Sweating—Doxorubicin—kidney cancer	0.00031	0.00285	CcSEcCtD
Terbutaline—Rash—Vincristine—kidney cancer	0.00031	0.00285	CcSEcCtD
Terbutaline—Hyperhidrosis—Capecitabine—kidney cancer	0.000309	0.00284	CcSEcCtD
Terbutaline—Dermatitis—Vincristine—kidney cancer	0.000309	0.00284	CcSEcCtD
Terbutaline—Headache—Vincristine—kidney cancer	0.000308	0.00283	CcSEcCtD
Terbutaline—Vomiting—Gemcitabine—kidney cancer	0.000296	0.00272	CcSEcCtD
Terbutaline—Rash—Gemcitabine—kidney cancer	0.000294	0.0027	CcSEcCtD
Terbutaline—Dermatitis—Gemcitabine—kidney cancer	0.000294	0.0027	CcSEcCtD
Terbutaline—Headache—Gemcitabine—kidney cancer	0.000292	0.00268	CcSEcCtD
Terbutaline—Nausea—Vincristine—kidney cancer	0.000292	0.00268	CcSEcCtD
Terbutaline—Insomnia—Capecitabine—kidney cancer	0.00029	0.00266	CcSEcCtD
Terbutaline—Paraesthesia—Capecitabine—kidney cancer	0.000287	0.00264	CcSEcCtD
Terbutaline—Dyspnoea—Capecitabine—kidney cancer	0.000285	0.00262	CcSEcCtD
Terbutaline—Asthenia—Paclitaxel—kidney cancer	0.00028	0.00257	CcSEcCtD
Terbutaline—Nausea—Gemcitabine—kidney cancer	0.000277	0.00254	CcSEcCtD
Terbutaline—Flushing—Doxorubicin—kidney cancer	0.00027	0.00248	CcSEcCtD
Terbutaline—Dizziness—Paclitaxel—kidney cancer	0.000258	0.00237	CcSEcCtD
Terbutaline—Tension—Doxorubicin—kidney cancer	0.000248	0.00228	CcSEcCtD
Terbutaline—Vomiting—Paclitaxel—kidney cancer	0.000248	0.00228	CcSEcCtD
Terbutaline—Rash—Paclitaxel—kidney cancer	0.000246	0.00226	CcSEcCtD
Terbutaline—Dermatitis—Paclitaxel—kidney cancer	0.000246	0.00226	CcSEcCtD
Terbutaline—Nervousness—Doxorubicin—kidney cancer	0.000246	0.00226	CcSEcCtD
Terbutaline—Headache—Paclitaxel—kidney cancer	0.000244	0.00225	CcSEcCtD
Terbutaline—Muscle spasms—Doxorubicin—kidney cancer	0.000243	0.00223	CcSEcCtD
Terbutaline—Nausea—Paclitaxel—kidney cancer	0.000232	0.00213	CcSEcCtD
Terbutaline—Asthenia—Capecitabine—kidney cancer	0.00023	0.00211	CcSEcCtD
Terbutaline—Palpitations—Doxorubicin—kidney cancer	0.000223	0.00205	CcSEcCtD
Terbutaline—Chest pain—Doxorubicin—kidney cancer	0.000215	0.00198	CcSEcCtD
Terbutaline—Anxiety—Doxorubicin—kidney cancer	0.000215	0.00197	CcSEcCtD
Terbutaline—Dizziness—Capecitabine—kidney cancer	0.000212	0.00195	CcSEcCtD
Terbutaline—Dry mouth—Doxorubicin—kidney cancer	0.000211	0.00193	CcSEcCtD
Terbutaline—Vomiting—Capecitabine—kidney cancer	0.000204	0.00187	CcSEcCtD
Terbutaline—Rash—Capecitabine—kidney cancer	0.000202	0.00185	CcSEcCtD
Terbutaline—Dermatitis—Capecitabine—kidney cancer	0.000202	0.00185	CcSEcCtD
Terbutaline—Tachycardia—Doxorubicin—kidney cancer	0.000201	0.00185	CcSEcCtD
Terbutaline—Headache—Capecitabine—kidney cancer	0.000201	0.00184	CcSEcCtD
Terbutaline—Hyperhidrosis—Doxorubicin—kidney cancer	0.000199	0.00183	CcSEcCtD
Terbutaline—Nausea—Capecitabine—kidney cancer	0.00019	0.00175	CcSEcCtD
Terbutaline—Insomnia—Doxorubicin—kidney cancer	0.000187	0.00172	CcSEcCtD
Terbutaline—Paraesthesia—Doxorubicin—kidney cancer	0.000185	0.0017	CcSEcCtD
Terbutaline—Dyspnoea—Doxorubicin—kidney cancer	0.000184	0.00169	CcSEcCtD
Terbutaline—Somnolence—Doxorubicin—kidney cancer	0.000183	0.00169	CcSEcCtD
Terbutaline—Asthenia—Doxorubicin—kidney cancer	0.000148	0.00136	CcSEcCtD
Terbutaline—Dizziness—Doxorubicin—kidney cancer	0.000136	0.00125	CcSEcCtD
Terbutaline—Vomiting—Doxorubicin—kidney cancer	0.000131	0.00121	CcSEcCtD
Terbutaline—Rash—Doxorubicin—kidney cancer	0.00013	0.0012	CcSEcCtD
Terbutaline—Dermatitis—Doxorubicin—kidney cancer	0.00013	0.00119	CcSEcCtD
Terbutaline—Headache—Doxorubicin—kidney cancer	0.000129	0.00119	CcSEcCtD
Terbutaline—Nausea—Doxorubicin—kidney cancer	0.000123	0.00113	CcSEcCtD
